DBPR108|DBPR-108,DPP4 inhibitor|DC Chemicals

Cas No.:	1186426-66-3
Synonyms:	DBPR-108,DBPR 108
SMILES:	N#C[C@H]1N(C(CNC(C)(C)CC(N2CCCC2)=O)=O)C[C@@H](F)C1
Formula:	C₁₆H₂₅FN₄O₂
M.Wt:	324.39
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

For the detailed information of DBPR108, the solubility of DBPR108 in water, the solubility of DBPR108 in DMSO, the solubility of DBPR108 in PBS buffer, the animal experiment (test) of DBPR108, the cell expriment (test) of DBPR108, the in vivo, in vitro and clinical trial test of DBPR108, the EC50, IC50,and affinity,of DBPR108, For the detailed information of DBPR108, the solubility of DBPR108 in water, the solubility of DBPR108 in DMSO, the solubility of DBPR108 in PBS buffer, the animal experiment (test) of DBPR108, the cell expriment (test) of DBPR108, the in vivo, in vitro and clinical trial test of DBPR108, the EC50, IC50,and affinity,of DBPR108, Please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC8108	DBPR108	DBPR108 is a potent, selective, and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM; no inhibition on DDP8 and DPP9. IC50 value: 15 Nm.
DC11899	Gosogliptin dihydrochloride	A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM.
DC11898	Gosogliptin	A potent, selective, competitive, orally active dipeptidyl peptidase-4 (DPP-4) inhibitor with IC50 of 13 nM.
DC11536	Imigliptin dihydrochloride	A novel potent, selective, orally available DPP-4 inhibitor with IC50 of 9 nM.